Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Latamoxef and the newborn.

J de Louvois, J James, A Mulhall

    Archives of Disease in Childhood
    |April 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Latamoxef (Moxalactam) is a safe and effective antibiotic for treating infections in preterm neonates. It demonstrated efficacy in clearing bacteria, including Group B streptococci, with no adverse effects on organ function or bilirubin levels.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    In situ differences in nitrogen cycling related to presence of submerged aquatic vegetation in a Gulf of Mexico estuary.

    Ecosphere (Washington, D.C)·2024
    Same author

    The role of contrast-enhanced mammography in the preoperative evaluation of invasive lobular carcinoma of the breast.

    Clinical radiology·2024
    Same author

    Introducing LISA: Less Invasive Surfactant Administration.

    Irish medical journal·2023
    Same author

    Impact of the COVID-19 pandemic on a post-mortem CT service for adult non-suspicious death.

    Clinical radiology·2023
    Same author

    Arfid Genes and Environment (ARFID-GEN): Study Protocol.

    Research square·2023
    Same author

    Long COVID prevalence and associated characteristics among a South Alabama population.

    Public health·2023

    Area of Science:

    • Neonatal Medicine
    • Infectious Diseases
    • Pharmacology

    Background:

    • Preterm neonates with infections often receive gentamicin and penicillin.
    • There is a need for safe and effective alternative antibiotics in neonatal care.

    Purpose of the Study:

    • To evaluate the safety and efficacy of latamoxef (Moxalactam) in treating preterm neonates with suspected infections.
    • To compare latamoxef's outcomes with traditional treatments like gentamicin and penicillin.

    Main Methods:

    • Prospective study of 31 preterm neonates treated with latamoxef (100 mg/kg/day).
    • Monitoring for clinical improvement, side effects, biochemical and haematological values.
    • Pharmacokinetic variables were determined following intravenous or intramuscular administration.

    Related Experiment Videos

    Main Results:

    • Thirty of 31 neonates showed clinical improvement.
    • Latamoxef eradicated infecting organisms in 7 of 9 cases, including Group B streptococci.
    • High serum concentrations were achieved without accumulation; no adverse effects on renal/hepatic function or bilirubin levels were observed. Two disulfiram-like reactions occurred.

    Conclusions:

    • Latamoxef is a safe and efficacious alternative to gentamicin with penicillin for initial neonatal infection treatment.
    • The antibiotic demonstrated good pharmacokinetic properties and a favorable safety profile in the studied preterm neonate population.